In keeping with our cell line analysis, patients with more aggressive tumours (basal-like and triple-negative) (n = 204) expressed significantly higher C1orf106 mRNA than non-basal and not triple-negative tumours (TNBC) (n = 2370) (Figure 6a). This evidence concerns the gene INAVA and neoplasm.